NCT02138474

Brief Summary

Chronic tension-type headaches (CTTHs) affect 30-40% of the population and account for a number of absences from, and decreased performances at, work and school as well as recreational activities. CTTHs typically occur at least 15 times a month or at least every second day, and present as an achy or tight sensation that is felt around the head . The pain may last from 30 minutes to several days and varies in intensity . Conventional treatment is palliative, consisting of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), which may produce adverse effects and analgesic rebound headaches . Lacticum acidum 30CH is a homoeopathic remedy that has been shown to have potential benefits in the treatment of CTTHs . Homaccords are the preparation of one remedy in multiple increasing potencies in a single vehicle . There has been no research done to date on Lacticum acidum Homaccord in the treatment of CTTHs.The aim of this study is to determine the efficacy of Lacticum acidum Homaccord in the treatment of chronic tension-type headaches, using the modified Headache Diary and the Headache Disability Inventory.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Apr 2014

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 12, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 14, 2014

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

May 17, 2016

Status Verified

May 1, 2016

Enrollment Period

2 months

First QC Date

May 12, 2014

Last Update Submit

May 16, 2016

Conditions

Keywords

Lacticum acidum homaccordhomeopathychronic tension-type headaches

Outcome Measures

Primary Outcomes (1)

  • modified Headache Diary and the Headache Disability Inventory.

    one month

Study Arms (2)

Lacticum acidum homaccord

EXPERIMENTAL

Lacticum acidum homaccord 30 mL bottle of medicated sucrose pillules take 5 pillules of the medication in the morning and in the evening for 4 weeks

Other: Lacticum acidum homaccord

Placebo

PLACEBO COMPARATOR

Unmedicated sucrose pillules, take 5 pillules twice daily for 4 weeks

Other: Placebo

Interventions

Homeopathic remedy, made using sucrose pillules

Lacticum acidum homaccord
PlaceboOTHER

Unmedicated sucrose pillules

Placebo

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Are male or female participants between the ages of 18 and 45 years;
  • Fit the diagnostic criteria for CTTHs: headache occurring for 15 days a month or more, for a period of more than 3 months a year and lasts for hours or may be continuous. The headache should have at least one of the following characteristics: 1. bilateral location; 2. pressing/tightening (non-pulsating) quality; 3. mild or moderate intensity, 4. aggravated by normal physical activities such as walking or climbing stairs; and at least one of the characteristics in the following categories: 5.1. photophobia, phonophobia or mild nausea, and 5.2. moderate or severe nausea or vomiting ; and
  • Fit eight out of the twelve headache-related symptom criteria for Lacticum acidum .

You may not qualify if:

  • Have history of headache or a change in their normal pattern or type of headache over the previous three months;
  • Have had any head, neck or back injury in the previous month;
  • Suffer from rheumatoid arthritis, a suspected tumour or vision problems;
  • Use opioids or analgesics for more than 15 days a month, for more than three months a year;
  • Use chronic medication such as corticosteroids, antidepressants, anti-hypertensives; and / or
  • Are pregnant or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UJ

Johannesburg, Gauteng, 2028, South Africa

Location

Study Officials

  • Radmila Razlog, M.Tech Hom

    UJ

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

May 12, 2014

First Posted

May 14, 2014

Study Start

April 1, 2014

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

May 17, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

Locations